Navigation Links
MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
Date:8/4/2008

VALENCIA, Calif., Aug. 4 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) will release its 2008 second quarter financial results on Monday, August 11, 2008 at 4:00 p.m. EDT.

Management of the Company will host a conference call to discuss the second quarter financial results, clinical progress and other Company developments at 5:00 p.m. EDT on Monday, August 11, 2008. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President and Chief Financial Officer, Matthew Pfeffer and Corporate Vice President and Chief Scientific Officer, Peter Richardson.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (800) 219-6350 or (402) 220-3904. A replay will also be available on MannKind's website for fourteen days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere Insulin System, is currently in Phase 3 clinical trials in the United States
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MannKind to Present at the UBS Global Life Sciences Conference
2. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
3. MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
4. MannKind to Present at the Piper Jaffray Healthcare Conference
5. MannKind to Present at the Wachovia 2008 Healthcare Conference
6. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
8. MannKind Corporation Response to Recent Market Events
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
11. MannKind to Present at the Morgan Stanley Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)....,Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(...blishedNovember27,2009astheex-dividenddateforits$2...mthesecuritizationtransactioncompletedonNovember2,...ockholdersofrecordontherecorddate,December1,2009.N...ndat$1.67pershareofcommonstockforpurposesoftheex-d...
(Date:11/23/2009)...PRNewswire/-InimexPharmaceuticals,Inc.announcedtod...dentandCEO. ,, Abramsbringsmorethan25yearsofdru...-inventorofthenuclearmedicineimagingagent,Cardioli...ehewasManager,BiomedicalResearchWorldwide.In1996,A...sPresidentandCEOfrom1996to2006.AnorMEDdiscoveredan...
(Date:11/20/2009)... countries have an opportunity to take the lead in... the University of Valencia (UV), working together...ductive fabric of the Spanish biotechnology indust...t sectors have more clout than those in English-sp...food and plants has been overlooked by the leading...
(Date:11/20/2009)...v. 20 Cell Therapeutics,... that the Ninth Circuit Court of Appeals reversed ...uld be allowed to pursue all of its claims against...rict Court for trial. CTI filed a complaint again...rsement consultant for CTI,s product TRISENOX, in ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
... 12 /PRNewswire-FirstCall/ - Neptune Technologies ...V.NTB), "Neptune" today,announced its results for ...e,s Highlights:, - First Quarter ended August 3...5,000 compared to $1,552,000, for the fir...., - EBITDA increased by 10% to $332,000 co...
... on Global List for Fifth Consecutive Year, CAMBR... GENZ ) announced today that scientists have agai...king the reputations of biotechnology and,pharmace...nearly 500,companies. Over the past five years Gen...ll biotechnology and pharmaceutical companies. Gen...
...fforts to Expand Market and Prepare for Zingo Laun...y Donahue Promoted To Senior Vice President, Marke...To Vice President, Marketing - - Addit...s to be Presented at Investor Briefing Today at 12... -, SOUTH SAN FRANCISCO, Calif., Oct. 12 Anesiva...
Other Biology Technology:Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update 2Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update 3Genzyme Recognized by Scientists as a Top Employer 2Genzyme Recognized by Scientists as a Top Employer 3Genzyme Recognized by Scientists as a Top Employer 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 2Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 3Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 5Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 6Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 7
(Date:11/23/2009)...-- A USDOE and USDA study concluded that 50 millio...and pasture could be converted from current uses t...tchgrass, from which biomass could be harvested fo...production of a perennial grass monoculture from w... annually is expected to require nitrogen fertiliz...
(Date:11/23/2009)...ew Hampshire microbiologist Louis Tisa has receive...nding of the actinorhizal plants, widespread woody... contaminated soils. , The United States Depart...or of molecular, cellular and biomedical sciences,...tween the bacteria Frankia and Casuarina, an actin...
(Date:11/23/2009)...rnia biomedical engineer and cardiologist Tzung "J...nicians distinguish cardiac emergencies requiring ... with drugs and lifestyle change. , Angiograms, ...s feeding the heart, offer an inside view of the i...often revealing deposits of a dangerous fatty subs...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept 29 14029 1Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept 29 14029 2Sage Products Launches Comprehensive Wellness Program with EngagementHealth 28R 29 57094 1Sage Products Launches Comprehensive Wellness Program with EngagementHealth 28R 29 57094 2Life Saving Alternative to the Smoke Alarm Wins the 2009 James Dyson Award 57090 1Life Saving Alternative to the Smoke Alarm Wins the 2009 James Dyson Award 57090 2Life Saving Alternative to the Smoke Alarm Wins the 2009 James Dyson Award 57090 3
...at surround and protect nerves could lead to new t...le sclerosis, a research team reports in the May 1...he approach grew out of a novel explanation, quick...amage caused by multiple sclerosis. Instead of co...immune assaults on the nervous system, researchers...
...targeted cells through the design of specific mole...ding Blocks) has won a prestigious scientific priz...Hebrew University of Jerusalem , Jerusalemite Nir ...Innovation Award on June 13, during the 69th meeti..., Qvit has shown through his research that it is ...
...ronounce it. Although it is found in many organism...as remained a mouthful for laymen and a puzzle for...alls these cellular lipids, are important in numer...ission. , Now, for the first time, cellular biolog...ew tools to study and localize GPIs in living orga...
Other Biology News:Selectively blocking inflammatory signals may protect mice from MS 2New understanding of parasite cell structures may provide treatments for serious tropical diseases 2New understanding of parasite cell structures may provide treatments for serious tropical diseases 3
...ion through targeting resequencing. This service ...alidation/optimization, high throughput PCR setup ...mples and sequence alignment and analysis.,Agenco...highly accurate identification of SNP loci. SNPs a...
Pre-Validated Kinase Polymorphism Assays from Agencourt Bioscience
...g medium designed for the preservation of fluoresc...lly recommended when using tracers containing phyc...lue. It can also be used with conventional fluores... (TMRITC) and Texas Red. Gel/Mount is a non-glycer...
...ulated for covering tissue sections and cell prepa...ens producing alcohol soluble OR alcohol insoluble...ion: Vision Mount can be used with chromogens suc...ing medium, or those that do not, such as DAB. No...
Biology Products: